These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35091204)

  • 21. Validation of a visual analog scale for assessing cough severity in patients with chronic cough.
    Martin Nguyen A; Bacci ED; Vernon M; Birring SS; Rosa C; Muccino D; Schelfhout J
    Ther Adv Respir Dis; 2021; 15():17534666211049743. PubMed ID: 34697975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial.
    Ryan NM; Birring SS; Gibson PG
    Lancet; 2012 Nov; 380(9853):1583-9. PubMed ID: 22951084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Behavioral Cough Suppression Therapy Delivered via Telehealth.
    Sundholm N; Shelly S; Wright ML; Reynolds J; Slovarp L; Gillespie AI
    J Voice; 2022 Dec; ():. PubMed ID: 36550001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy of gabapentin for the treatment of refractory cough associated with interstitial lung disease: study protocol for a randomized, double-blind and placebo-controlled clinical trial.
    Gao R; Xu X; Wang S; Pu J; Shi C; Wen S; Zhu Y; Tang J; Wang X; Yu L
    Trials; 2022 Feb; 23(1):165. PubMed ID: 35189953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Speech Pathology Intervention for Chronic Refractory Cough: A Pilot Study Examining the Benefit of Using Prerecorded Videos as an Adjunct to Therapy.
    Kapela SL; Vertigan AE; Gibson PG
    J Voice; 2020 Jul; 34(4):647.e7-647.e14. PubMed ID: 30639153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-Term Treatment Outcomes after Behavioral Speech Therapy for Chronic Refractory Cough.
    Wright ML; Sundar KM; Herrick JS; Barkmeier-Kraemer JM
    Lung; 2021 Oct; 199(5):517-525. PubMed ID: 34595607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short- and Long-term Effects of Neuromodulators for Unexplained Chronic Cough.
    Bowen AJ; Nowacki AS; Contrera K; Trask D; Kaltenbach J; Milstein CF; Adessa M; Benninger MS; Taliercio R; Bryson PC
    Otolaryngol Head Neck Surg; 2018 Sep; 159(3):508-515. PubMed ID: 29634404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flupentixol/melitracen for chronic refractory cough after treatment failure with other neuromodulators.
    Chen Q; Zhang M; Si F; Wang S; Xu X; Yu L; Lai K; Qiu Z
    Int J Tuberc Lung Dis; 2021 Aug; 25(8):648-654. PubMed ID: 34330350
    [No Abstract]   [Full Text] [Related]  

  • 29. A Randomized Controlled Trial to Assess the Effect of Lidocaine Administered via Throat Spray and Nebulization in Patients with Refractory Chronic Cough.
    Abdulqawi R; Satia I; Kanemitsu Y; Khalid S; Holt K; Dockry R; Woodcock AA; Smith JA
    J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1640-1647. PubMed ID: 33259976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Pregabalin as a Neural Pathway Inhibitor for the Treatment of Resistant Subacute and Chronic Cough: A Pilot Clinical Trials Study.
    Adeli SH; Beigi AM; Ahmadpour S; Habibi MA; Pashaei MR; Sharifipour E; Shakeri M; Asghari A
    Rev Recent Clin Trials; 2023; 18(4):269-274. PubMed ID: 37888808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of proton pump inhibitor in unexplained chronic cough.
    Park HJ; Park YM; Kim JH; Lee HS; Kim HJ; Ahn CM; Byun MK
    PLoS One; 2017; 12(10):e0185397. PubMed ID: 29016626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tiotropium Attenuates Refractory Cough and Capsaicin Cough Reflex Sensitivity in Patients with Asthma.
    Fukumitsu K; Kanemitsu Y; Asano T; Takeda N; Ichikawa H; Yap JMG; Fukuda S; Uemura T; Takakuwa O; Ohkubo H; Maeno K; Ito Y; Oguri T; Nakamura A; Takemura M; Niimi A
    J Allergy Clin Immunol Pract; 2018; 6(5):1613-1620.e2. PubMed ID: 29408386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improvement in health status following cough-suppression physiotherapy for patients with chronic cough.
    Patel AS; Watkin G; Willig B; Mutalithas K; Bellas H; Garrod R; Pavord ID; Birring SS
    Chron Respir Dis; 2011; 8(4):253-8. PubMed ID: 21990570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhaled corticosteroids for subacute and chronic cough in adults.
    Johnstone KJ; Chang AB; Fong KM; Bowman RV; Yang IA
    Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD009305. PubMed ID: 23543575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Electronic Cigarette Use on the Urge-to-Cough Sensation.
    Dicpinigaitis PV; Lee Chang A; Dicpinigaitis AJ; Negassa A
    Nicotine Tob Res; 2016 Aug; 18(8):1763-5. PubMed ID: 26803150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. XEN-D0501, a Novel Transient Receptor Potential Vanilloid 1 Antagonist, Does Not Reduce Cough in Patients with Refractory Cough.
    Belvisi MG; Birrell MA; Wortley MA; Maher SA; Satia I; Badri H; Holt K; Round P; McGarvey L; Ford J; Smith JA
    Am J Respir Crit Care Med; 2017 Nov; 196(10):1255-1263. PubMed ID: 28650204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant.
    Morice AH; Birring SS; Smith JA; McGarvey LP; Schelfhout J; Martin Nguyen A; Xu ZJ; Wu WC; Muccino DR; Sher MR
    Lung; 2021 Apr; 199(2):121-129. PubMed ID: 33825965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial.
    Smith JA; Kitt MM; Morice AH; Birring SS; McGarvey LP; Sher MR; Li YP; Wu WC; Xu ZJ; Muccino DR; Ford AP;
    Lancet Respir Med; 2020 Aug; 8(8):775-785. PubMed ID: 32109425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized Controlled Pilot Trial of Behavioral Insomnia Treatment for Chronic Migraine With Comorbid Insomnia.
    Smitherman TA; Walters AB; Davis RE; Ambrose CE; Roland M; Houle TT; Rains JC
    Headache; 2016 Feb; 56(2):276-91. PubMed ID: 26813845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.